메뉴 건너뛰기




Volumn 38, Issue 6, 2014, Pages 843-844

Magnetic resonance imaging repercussions of intravenous iron products used for iron-deficiency anemia and dialysis-associated anemia

Author keywords

Hemodialysis; Hemosiderosis; Intravenous iron products; MRI

Indexed keywords

DIAGNOSIS; DISEASE CONTROL; HEMODIALYZERS; IRON; MAGNETIC RESONANCE IMAGING; PATIENT TREATMENT;

EID: 84918568238     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/rct.0000000000000146     Document Type: Article
Times cited : (9)

References (12)
  • 1
    • 84904740773 scopus 로고    scopus 로고
    • The long-lasting effect of ferumoxytol on abdominal magnetic resonance imaging
    • Harman A, Chang KJ, Dupuy D, et al. The long-lasting effect of ferumoxytol on abdominal magnetic resonance imaging. J Comput Assist Tomogr. 2014;38:571-573.
    • (2014) J Comput Assist Tomogr. , vol.38 , pp. 571-573
    • Harman, A.1    Chang, K.J.2    Dupuy, D.3
  • 2
    • 85038654650 scopus 로고    scopus 로고
    • Rienso. European Medicines Agency. Available at
    • Rienso. EPAR. European Medicines Agency. Available at: http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Public-assessment-report/human/002215/WC500129751.pdf.
    • EPAR.1
  • 3
    • 84857619411 scopus 로고    scopus 로고
    • Supermagnetic iron oxide based MRI contras agents: Current status of clinical applications
    • Wang Y-X. Supermagnetic iron oxide based MRI contras agents: current status of clinical applications. Quant Imaging Med Surg. 2011;1:35-404.
    • (2011) Quant Imaging Med Surg. , vol.1 , pp. 35-404
    • Wang, Y.-X.1
  • 4
    • 84900031525 scopus 로고    scopus 로고
    • Bone marrow uptake of ferumoxytol: A preliminary study in healthy human subjects
    • Storey P, Arbini AA. Bone marrow uptake of ferumoxytol: a preliminary study in healthy human subjects. J Magn Reson Imaging. 2014;39:1401-1410.
    • (2014) J Magn Reson Imaging. , vol.39 , pp. 1401-1410
    • Storey, P.1    Arbini, A.A.2
  • 5
    • 84870057819 scopus 로고    scopus 로고
    • MRI assessment of hepatic iron clearance rates after USPIO administration in healthy adults
    • Storey P, Lim R P, Chandrana H, et al. MRI assessment of hepatic iron clearance rates after USPIO administration in healthy adults. Invest Radiol. 2012;47:717-724.
    • (2012) Invest Radiol. , vol.47 , pp. 717-724
    • Storey, P.1    Lim, R.P.2    Chandrana, H.3
  • 6
    • 84864286737 scopus 로고    scopus 로고
    • Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: AMRI study
    • Rostoker G, Griuncelli M, Loridon C, et al. Hemodialysis-associated hemosiderosis in the era of erythropoiesis-stimulating agents: aMRI study. Am J Med. 2012;125:991-999.
    • (2012) Am J Med. , vol.125 , pp. 991-999
    • Rostoker, G.1    Griuncelli, M.2    Loridon, C.3
  • 7
    • 0032589102 scopus 로고    scopus 로고
    • Kinetic analysis of 52Fe-labelled iron (III) hydroxyde-sucrose complex following bolus administration using positron emission tomography
    • Beshara S, Lundqvist H, Sundin J, et al. Kinetic analysis of 52Fe-labelled iron (III) hydroxyde-sucrose complex following bolus administration using positron emission tomography. Br J Haematol. 1999;104:288-295.
    • (1999) Br J Haematol. , vol.104 , pp. 288-295
    • Beshara, S.1    Lundqvist, H.2    Sundin, J.3
  • 8
    • 0032934971 scopus 로고    scopus 로고
    • Pharmacokinetic and red cell utilization of iron (III) hydroxyde-sucrose complex in anaemic patients: A study using positron emission tomography
    • Beshara S, Lundqvist H, Sundin J, et al. Pharmacokinetic and red cell utilization of iron (III) hydroxyde-sucrose complex in anaemic patients: a study using positron emission tomography. Br J Haematol. 1999;104: 296-302.
    • (1999) Br J Haematol. , vol.104 , pp. 296-302
    • Beshara, S.1    Lundqvist, H.2    Sundin, J.3
  • 9
    • 0037335627 scopus 로고    scopus 로고
    • Pharmacokinetic and red cell utilization of 52Fe/59-labelled iron polymaltose complex in anaemic patients using positron emission tomography
    • Beshara S, Sörensen J, Lubberink M, et al. Pharmacokinetic and red cell utilization of 52Fe/59-labelled iron polymaltose complex in anaemic patients using positron emission tomography. Br J Haematol. 2003;120: 853-859.
    • (2003) Br J Haematol. , vol.120 , pp. 853-859
    • Beshara, S.1    Sörensen, J.2    Lubberink, M.3
  • 10
    • 84918590099 scopus 로고    scopus 로고
    • American regebt expands promotional campain for iron deficiency anemia drug Injectafer. Accessed January 23
    • American regebt expands promotional campain for iron deficiency anemia drug Injectafer. http://drugdelivery.pharmaceutical-business-review.com/news/american-regent-expands-promotional-campaign-for-iron-deficiencyanemia-drug-injectafer-230114-4164130. Accessed January 23, 2014.
    • (2014)
  • 11
    • 79953724862 scopus 로고    scopus 로고
    • The pharmacokinetics and pharmacodynamics of iron preparations
    • Geisser P, Burkhardt S. The pharmacokinetics and pharmacodynamics of iron preparations. Pharmaceutics. 2011;3:12-33.
    • (2011) Pharmaceutics. , vol.3 , pp. 12-33
    • Geisser, P.1    Burkhardt, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.